Faron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Below 50 Day Moving Average - Time to Sell?

Faron Pharmaceuticals Oy (LON:FARN - Get Free Report)'s stock price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 203.53 ($2.62) and traded as low as GBX 155.75 ($2.00). Faron Pharmaceuticals Oy shares last traded at GBX 162.50 ($2.09), with a volume of 8,437 shares changing hands.

Faron Pharmaceuticals Oy Stock Down 7.7 %

The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09. The firm's 50-day moving average price is GBX 203.53 and its 200 day moving average price is GBX 169.61. The firm has a market cap of £156.98 million, a P/E ratio of -484.38 and a beta of 0.36.

Faron Pharmaceuticals Oy Company Profile

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.